Balyasny Asset Management’s BioNTech BNTX Stock Holding History

Balyasny Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Hold	12,500	–	–	﹤0.01%	2124
2026 Q1	$1.11M	Sell	12,500 -5,500	-31%	-$565K	﹤0.01%	2037
2025 Q4	$1.71M	Buy	+18,000	New	+$1.81M	﹤0.01%	1943
2025 Q2	–	Sell	-101,700	Closed	-$9.26M	–	2849
2025 Q1	$9.26M	Buy	+101,700	New	+$11.4M	0.02%	953
2024 Q4	–	Sell	-5,400	Closed	-$641K	–	2759
2024 Q3	$641K	Buy	+5,400	New	+$496K	﹤0.01%	2161
2021 Q4	–	Sell	-65,000	Closed	-$17.7M	–	2254
2021 Q3	$17.7M	Buy	65,000 +52,000	+400%	+$16.5M	0.07%	378
2021 Q2	$2.91M	Sell	13,000 -156,000	-92%	-$29.4M	0.01%	897
2021 Q1	$18.5M	Buy	169,000 +64,000	+61%	+$6.8M	0.09%	299
2020 Q4	$8.56M	Buy	105,000 +55,000	+110%	+$5.4M	0.05%	476
2020 Q3	$3.46M	Buy	+50,000	New	+$3.59M	0.03%	700

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Balyasny Asset Management's BNTX Position: Q2 2026 in Review

Balyasny Asset Management increased its BioNTech (BNTX) stake by 396% in Q2 2026, buying an estimated $34.8M and bringing the position to 463,163 shares worth $43.1M. The position accounts for 0.05% of the portfolio, ranked #412.

Balyasny Asset Management first reported a position in BNTX in Q2 2020 and has held it in 16 quarters since. The position peaked at $73.7M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Balyasny Asset Management held 463,163 shares of BioNTech worth $43.1M as of Q2 2026.
Balyasny Asset Management bought 369,708 BioNTech shares in Q2 2026, an estimated $34.8M.
BioNTech made up 0.05% of Balyasny Asset Management's portfolio in Q2 2026, its #412 holding.
Balyasny Asset Management first reported a position in BioNTech in Q2 2020 and has held it in 16 quarters since.
Balyasny Asset Management's BioNTech position peaked at $73.7M in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.